Selective targeting of α4β1 integrin attenuates murine graft versus host disease

Bader Alahmari; Matthew L. Cooper; Kiran Vij; Julie Ritchey; Peter Ruminski; Feng Gao; Jaebok Choi; John F. DiPersio

doi:10.1038/s41375-020-0786-0

Selective targeting of α4β1 integrin attenuates murine graft versus host disease

Bader Alahmari
, Matthew L. Cooper
, Kiran Vij
, Julie Ritchey
, Peter Ruminski
, Feng Gao
, Jaebok Choi
, John F. DiPersio

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	3100-3104
Number of pages	5
Journal	Leukemia
Volume	34
Issue number	11
DOIs	https://doi.org/10.1038/s41375-020-0786-0
State	Published - Nov 1 2020

Access to Document

10.1038/s41375-020-0786-0

Cite this

@article{5abeb652014e41f0bb7f5cec8cf5e5ce,

title = "Selective targeting of α4β1 integrin attenuates murine graft versus host disease",

author = "Bader Alahmari and Cooper, \{Matthew L.\} and Kiran Vij and Julie Ritchey and Peter Ruminski and Feng Gao and Jaebok Choi and DiPersio, \{John F.\}",

note = "Funding Information: Acknowledgements JC is supported by Washington University SPORE-CDP (P50 CA171963-01), the Bryan Thomas Campbell Foundation, The Amy Strelzer Manasevit Research Program (Be The Match Foundation and National Marrow Donor Program), The Rays of Hope St. Baldrick{\textquoteright}s Research Grant (St. Baldrick{\textquoteright}s Foundation), and Alvin J. Siteman Cancer Center Siteman Investment Program (supported by the Foundation for Barnes-Jewish Hospital Cancer Frontier Fund, National Cancer Institute Cancer Center Support Grant, P30 CA091842, and Barnard Trust). JFD is supported by the National Cancer Institute (P50 CA94056-09, P50 CA171963-01, and R35 CA210084-01) and the Bryan Thomas Campbell Foundation. We thank Joel Eissenberg for critical reading of the manuscript.",

year = "2020",

month = nov,

day = "1",

doi = "10.1038/s41375-020-0786-0",

language = "English",

volume = "34",

pages = "3100--3104",

journal = "Leukemia",

issn = "0887-6924",

number = "11",

}

TY - JOUR

T1 - Selective targeting of α4β1 integrin attenuates murine graft versus host disease

AU - Alahmari, Bader

AU - Cooper, Matthew L.

AU - Vij, Kiran

AU - Ritchey, Julie

AU - Ruminski, Peter

AU - Gao, Feng

AU - Choi, Jaebok

AU - DiPersio, John F.

N1 - Funding Information: Acknowledgements JC is supported by Washington University SPORE-CDP (P50 CA171963-01), the Bryan Thomas Campbell Foundation, The Amy Strelzer Manasevit Research Program (Be The Match Foundation and National Marrow Donor Program), The Rays of Hope St. Baldrick’s Research Grant (St. Baldrick’s Foundation), and Alvin J. Siteman Cancer Center Siteman Investment Program (supported by the Foundation for Barnes-Jewish Hospital Cancer Frontier Fund, National Cancer Institute Cancer Center Support Grant, P30 CA091842, and Barnard Trust). JFD is supported by the National Cancer Institute (P50 CA94056-09, P50 CA171963-01, and R35 CA210084-01) and the Bryan Thomas Campbell Foundation. We thank Joel Eissenberg for critical reading of the manuscript.

PY - 2020/11/1

Y1 - 2020/11/1

UR - https://www.scopus.com/pages/publications/85081648752

U2 - 10.1038/s41375-020-0786-0

DO - 10.1038/s41375-020-0786-0

M3 - Letter

C2 - 32152466

AN - SCOPUS:85081648752

SN - 0887-6924

VL - 34

SP - 3100

EP - 3104

JO - Leukemia

JF - Leukemia

IS - 11

ER -

Selective targeting of α4β1 integrin attenuates murine graft versus host disease

Access to Document

Other files and links

Cite this